In India, GSK Takes A Deep Dive To Launch Revolade, Votrient At 75% Price Cut
This article was originally published in The Pink Sheet Daily
Executive Summary
Calibrating a medicine price to a lower level to suit local needs is not a new concept for GlaxoSmithKline, which uses a tiered pricing structure, generally calculated based on parameters like GDP, per capita income of a specific country, medical access quotients and health insurance programs.